Clinical Trials Browser

INDUSTRY × Neuroma, Acoustic × Clear all

Neuroma, Acoustic, Hearing Loss

NCT07503613 2026-04-06

Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy

Enrolling by invitation

100 enrolled

CNS

Neuroma, Acoustic, Hearing Loss

NCT06322342 2025-12-26

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Phase 2 Completed

18 enrolled

CNS

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

NCT02948790 2021-10-20

NeuriStim

Phase NA Completed

17 enrolled

CNS

Hearing Loss, Sensorineural, Neuroma, Acoustic

Clinical Trials

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

NeuriStim